Pacific Biosciences Of California | PACB - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agilent USD 7.12B 214M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Danaher USD 52.95B 415M 2026-03
General Electric Aerospace USD 18.06B 841M 2026-03
Illumina USD 2.68B 47M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Quidel USD 1.85B 69.1M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Standard Biotools USD 561.12M 136.83M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 2.56B 230.55M 2025-12